Search Results
Jun 24, 2026, 12:33 ET Start Genetic Announces Second Annual Genetic Testing Action Day on July 25, 2026
ANGELES, June 24, 2026 /PRNewswire/ -- As advances in genetic medicine create new opportunities for patients with rare diseases, congenital anomalies, developmental disabilities, epilepsy, inherited cancers, and other conditions, Start Genetic today announced the second
More news about: Start Genetic
Jun 24, 2026, 12:09 ET FOX NATION TEAMS UP WITH JACK CARR FOR NEW INVESTIGATIVE DOCUSERIES ON CARLOS THE JACKAL
of the most infamous attacks of the twentieth century. Featuring access to the only known recorded interview with Carlos himself, the series offers a rare look inside the mind of one of history's most wanted men. A trailer is available
More news about: Fox News Network, LLC
Jun 24, 2026, 11:57 ET Compliance Stakes Rise Fast as SECURE 2.0 and Restatements Overlap, Leading Retirement Solutions Reports
changes and evolving requirements Employers that establish and maintain workplace retirement plans, known as plan sponsors, are facing a rare convergence of compliance obligations as mandatory SECURE 2.0 amendments overlap with the IRS's next plan document restatement cycle. With major regulatory
More news about: Leading Retirement Solutions
Jun 24, 2026, 11:36 ET Une œuvre rare de David Hockney devrait être la vedette de la vente aux enchères chez Phillips à Londres, alors que la demande pour les œuvres de l'artiste ne cesse de s'intensifier
content:https://www.prnewswire.com/news-releases/une-uvre-rare-de-david-hockney-devrait-etre-la-vedette-de-la-vente-aux-encheres-chez-phillips-a-londres-alors-que-la-demande-pour-les-uvres-de-lartiste-ne-cesse-de-sintensifier-302809506.html
More news about: PHILLIPS
Jun 24, 2026, 11:28 ET Sojourn Lodging Announces Wild Cave Tours at Sojourn Grotto in Partnership with TennTours
excited to announce plans to introduce guided wild cave tours at its flagship Sojourn Resorts property in Sevierville, Tennessee, offering guests a rare opportunity to explore a remarkable underground world hidden beneath the Smoky Mountains.
More news about: Sojourn Lodging
Jun 24, 2026, 11:00 ET Bulleit Goes Two Decades Deep With New 20-Year-Old Straight Rye Whiskey
Limited to just 1,776 bottles, this ultra-rare Bulleit Straight Rye tips its hat to the grain that started it all SHELBYVILLE, Ky., June 24, 2026 /PRNewswire/
More news about: DIAGEO
Jun 24, 2026, 10:00 ET Trovy Raises $25 Million in Total Funding To Turn Every Home Into a Financial Asset
borrower experience. The Trovy card is issued by Cross River Bank pursuant to a license from Mastercard."TJ and Ashley have built something rare, and they have the backgrounds to match," said Henry Toole, Partner at Left Lane Capital. "The team has a wealth of fintech
More news about: Trovy
Jun 24, 2026, 10:00 ET MoEngage Acquires Aampe to Bring 1:1 Agentic Decisioning to B2C Marketing Teams
Co-founder and CEO, MoEngage."But what convinced me was the team behind it. Paul, Schaun, Sami, and the Aampe team have brought a rare combination of research depth and production rigor to one of the hardest problems in marketing. Together, we're going to define the next era of Agentic
More news about: MoEngage
Jun 24, 2026, 09:41 ET Petauri Named to MM+M Agency 100 2026
strong demand for experienced partners who can translate complex data into clinically meaningful narratives, particularly as innovation accelerates in rare and orphan diseases," Renick continued. "That demand is reflected in the growth of our Petauri Advance medical communications teams, whose deep expertise
More news about: Petauri
Jun 24, 2026, 09:25 ET Elk + Elk Welcomes Attorney Madeline M. Kelley: Elite Trial Advocate Joins Ohio's Personal Injury and Medical Malpractice Teams
high-exposure cases around the country, combined with her top 10 national ranking in trial advocacy in Law School, speaks volumes about her ability. She has a rare combination of strategic insight and courtroom presence that will immediately benefit our clients."While attending the Case Western Reserve School
More news about: Elk & Elk Co., Ltd.
Jun 24, 2026, 09:05 ET Kura Sushi USA and HoYoverse Launch an Interstellar Honkai: Star Rail Collaboration Featuring Monaka Sandwiches, Capsule Prizes, Giveaways, and an All-New Music Video
order.kurasushi.com, and DoorDash, except for the rare Sparkle and Aventurine acrylic swing charm.*Exclusive Kura Sushi Rewards Member Offers:Kura Sushi Rewards members will have more
More news about: Kura Sushi USA, Inc.
Jun 24, 2026, 09:00 ET Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research
Rare diseases affect an estimated 350 million people worldwide and remain among the most challenging conditions to diagnose and treat. More than 7,000 rare diseases have been identified, with over 250 new diseases described each
More news about: Metabolon, Inc.
Jun 24, 2026, 09:00 ET Metabolon Delivers Large-Scale Metabolomics Dataset to Genomics England's 100,000 Genomes Project to Advance Rare Disease Research
Rare diseases affect an estimated 350 million people worldwide and remain among the most challenging conditions to diagnose and treat. More than 7,000 rare diseases have been identified, with over 250 new diseases described each
More news about: Metabolon, Inc.
Jun 24, 2026, 09:00 ET Runlayer Raises $30M Series A to Help Enterprises Go All In On AI
down on Runlayer as the golden path for every workforce going AI-native," said Jake Storm, General Partner at Felicis. "Runlayer is one of those rare companies where the consequences of success are so large that almost nothing else matters. The team has found a powerful wedge by giving enterprises
More news about: Runlayer
Jun 24, 2026, 08:57 ET First-Ever Recommendations Call for Routine Iron Screening in People with Bleeding Disorders
rare factor deficiencies, and
More news about: National Bleeding Disorders Foundation
Jun 24, 2026, 08:01 ET EXTRA® Gum Drops an "EXTRA Time Anthem" with Artist Izzy Escobar, Inspiring Soccer Fans to Stay Present During High-Stakes Matches
with endless notifications, competing priorities and constant distractions, finding moments that truly capture our attention has become increasingly rare. Yet for soccer fans, one moment consistently breaks through the noise: extra time. Today, EXTRA® gum is celebrating one of sport's most captivating
More news about: Mars, Incorporated
Jun 24, 2026, 08:00 ET Becoming rentABLE Joins Novartis' "SMAshing My Limits And Going Places" Campaign to Expand Accessible Lodging for People Living with SMA
We're dreaming bigger, seeing further, and working to deliver experiences the community truly deserves."The Unmet NeedSMA is a rare, genetic neuromuscular disease that, when left untreated, can cause progressive muscle weakness, impacting breathing, swallowing and basic movement.1
More news about: Becoming rentABLE
Jun 24, 2026, 07:05 ET REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
"We are encouraged by the recent FDA trends in rare disease development, including our collaborative discussion with FDA regarding our Hunter Syndrome program, demonstrating that the accelerated approval pathway remains available and supported for rare diseases. The RGX-202 pivotal dataset directly aligns
More news about: REGENXBIO Inc.
Jun 24, 2026, 07:05 ET Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults
of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential
More news about: Viking Therapeutics, Inc.
Jun 24, 2026, 05:59 ET Tarek Samad appointed EVP, Head of Research & Development at Lundbeck
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S
Jun 24, 2026, 05:56 ET Tarek Samad appointed EVP, Head of Research & Development at Lundbeck
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S
Jun 24, 2026, 05:16 ET Global Times: Protecting Nyang River in Xizang, a practice in building a Beautiful China on snowy plateau
clearer river water, cleaner banks and more water birds stopping in the wetland. Black-necked cranes, ruddy shelducks and bar-headed geese are no longer rare sights for local residents.As the wetland environment has improved, more tourists have come for sightseeing. Some villagers have opened guesthouses
More news about: Global Times
Jun 24, 2026, 05:00 ET MoEngage Acquires Aampe to Bring 1:1 Agentic Decisioning to B2C Marketing Teams
together at an individual level. What impressed me equally was the team behind the technology. Paul, Schaun, Sami, and the entire Aampe team bring a rare combination of research depth and production rigor to one of the hardest problems in marketing. Together, we're building the future of agentic marketing,
More news about: MoEngage
Jun 24, 2026, 05:00 ET MoEngage Acquires Aampe to Bring 1:1 Agentic Decisioning to B2C Marketing Teams
together at an individual level. What impressed me equally was the team behind the technology. Paul, Schaun, Sami, and the entire Aampe team bring a rare combination of research depth and production rigor to one of the hardest problems in marketing. Together, we're building the future of agentic marketing,
More news about: MoEngage
Jun 24, 2026, 03:49 ET Lundbeck presents new Vyepti® (eptinezumab) and bocunebart migraine portfolio data at EAN 2026
challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.We are committed to fighting stigma and we act to improve health equity. We strive to
More news about: H. Lundbeck A/S